102421Imaging software to quantify salvageable brain tissue to select stroke patientsClosedCollaborative R&DInnovate UKWorldwide annually, 13,000,000 patients suffer a stroke. Mechanical clot removal (endovascular treatment) is expected to increase from 1% to 10% of patients, as recent studies show it improves patient outcome. It costs up to £23,000 per patient, making patient selection crucial for its adoption. Brainomix has developed the medical imaging software, e-ASPECTS to automate the clinically validated ASPECTS method on plain CT brain scans,measuring existing stroke damage. Brainomix will build on its know-how to design, develop and validate perfusion-ASPECTS, up to getting certifications for clinical use. This will automate ASPECTS on perfusion CTs (which measure blood flow in the brain) to measure tissue at risk and identify patients who can benefit from mechanical reopening of the artery. Brainomix founders’ international reputation in stroke will ensure the successful development and clinical adoption of perfusion-ASPECTS.